SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
株式会社新日本科学
Valuation
Fundamental ratios for the latest reported period.
Ticker: 2395
FY2025 · 2026-03-31
| Gross margin | 49.9% |
| Operating margin | 8.2% |
| Net margin | 14.0% |
| Return on equity | 13.2% |
| Return on assets | 4.3% |
| Revenue growth (YoY) | 0.3% |
| EPS (basic) | ¥109.69 |
| EPS growth (YoY) | -7.3% |
| Current ratio | 1.09x |
| Equity ratio | 33.0% |
| Book value / share | ¥1,035.76 |
| Free cash flow | 3,153 M |